GlassScriptPhysician profile
Delos R Clift
NPI 1356305742
$3,043.71
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,156 · 2020: $888.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $861.14 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $408.27 | 2019-2020 | |
| Medtronic Vascular, INC. | $355.71 | 2019 | |
| W. L. Gore & Associates, INC. | $342.82 | 2019-2020 | |
| Angiodynamics, INC. | $185.09 | 2019-2020 | |
| Cardiovascular Systems INC. | $162.40 | 2019-2020 | |
| Boston Scientific Corporation | $129.67 | 2019-2020 | |
| Kci USA, INC. | $125.00 | 2019 | |
| Teleflex LLC | $112.50 | 2019 | |
| Cook Medical LLC | $47.46 | 2019 | |
| Pfizer INC. | $41.85 | 2019 | |
| Getinge USA Sales, LLC | $19.31 | 2020 | |
| Ekos Corporation | $13.35 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Delos Clift listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.